We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

India's Generic Industry Sounds Alarm Over Planned Patent Overhaul

Law360 (September 9, 2004, 12:00 AM EDT) -- India’s generic drug industry has warned the government that a planned overhaul of the country’s patent law could lead to broad price hikes for essential drugs.

The chairman of the Indian Pharmaceutical Alliance, Habil Khorakiwala, told the Hindu newspaper that the adoption of the amended patent bill could lead to “a chaotic situation as several companies would be forced to withdraw their brands from the market and the innovator entity will be able to jack up prices, hurting patients.”

He expressed concern that even some essential...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.